Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 1
1990 2
1992 2
1993 2
1994 3
1996 2
1997 2
1999 2
2000 6
2001 1
2003 1
2004 1
2005 1
2006 1
2007 2
2008 4
2009 3
2010 3
2011 8
2012 7
2013 7
2014 7
2015 9
2016 5
2017 12
2018 5
2019 7
2020 10
2021 21
2022 11
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Page 1
Riboflavin is an antioxidant: a review update.
Olfat N, Ashoori M, Saedisomeolia A. Olfat N, et al. Br J Nutr. 2022 Nov 28;128(10):1887-1895. doi: 10.1017/S0007114521005031. Epub 2022 Feb 4. Br J Nutr. 2022. PMID: 35115064 Review.
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. Ahmed N, et al. JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184. JAMA Oncol. 2017. PMID: 28426845 Free PMC article. Clinical Trial.
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, Liu E, Dakhova O, Ashoori A, Corder A, Gray T, Wu MF, Liu H, Hicks J, Rainusso N, Dotti G, Mei Z, Grilley B, Gee A, Rooney CM, Brenner MK, Heslop HE, Wels WS, Wang LL, Anderson P, Gottschalk S. Ahmed N, et al. J Clin Oncol. 2015 May 20;33(15):1688-96. doi: 10.1200/JCO.2014.58.0225. Epub 2015 Mar 23. J Clin Oncol. 2015. PMID: 25800760 Free PMC article. Clinical Trial.
Superconductivity and strong interactions in a tunable moiré quasicrystal.
Uri A, de la Barrera SC, Randeria MT, Rodan-Legrain D, Devakul T, Crowley PJD, Paul N, Watanabe K, Taniguchi T, Lifshitz R, Fu L, Ashoori RC, Jarillo-Herrero P. Uri A, et al. Nature. 2023 Aug;620(7975):762-767. doi: 10.1038/s41586-023-06294-z. Epub 2023 Jul 19. Nature. 2023. PMID: 37468640
154 results